134 related articles for article (PubMed ID: 19932629)
1. IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.
Lepenies J; Wu Z; Stewart PM; Strasburger CJ; Quinkler M
Growth Horm IGF Res; 2010 Apr; 20(2):93-100. PubMed ID: 19932629
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
3. IGF system in children with congenital disorders of glycosylation.
Miller BS; Khosravi MJ; Patterson MC; Conover CA
Clin Endocrinol (Oxf); 2009 Jun; 70(6):892-7. PubMed ID: 19207313
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.
Holt RI; Baker AJ; Jones JS; Miell JP
Pediatr Transplant; 1998 Feb; 2(1):76-84. PubMed ID: 10084765
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin-like growth factor-1 system and exercise tolerance in patients with intermittent claudication.
Laurenzano E; Brevetti G; Lanero S; Brevetti L; Colao A; Chiariello M
Int Angiol; 2009 Jun; 28(3):202-8. PubMed ID: 19506539
[TBL] [Abstract][Full Text] [Related]
6. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
7. Derangements of the somatotropic hormone axis in chronic renal failure.
Tönshoff B; Blum WF; Mehls O
Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
[TBL] [Abstract][Full Text] [Related]
8. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
10. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
11. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
Ferrante E; Giavoli C; Porretti S; Vassallo E; Ronchi CL; Lania AG; Beck-Peccoz P; Spada A
Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
[TBL] [Abstract][Full Text] [Related]
15. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
Yildiz B; Kural N; Colak O; Ak I; Akcar N
Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
[TBL] [Abstract][Full Text] [Related]
16. Decreased ternary complex formation and predominance of a 29 kDa IGFBP-3 fragment in human fetal serum.
Bang P; Stangenberg M; Westgren M; Rosenfeld RG
Growth Regul; 1994 Jun; 4(2):68-76. PubMed ID: 7524886
[TBL] [Abstract][Full Text] [Related]
17. Increased degradation of insulin-like growth factor-I in serum from feed-deprived steers.
Wu M; Wang A; Bernard GC; Hall JB; Beal WE; Michael Akers R; Boisclair YR; Jiang H
Domest Anim Endocrinol; 2008 Nov; 35(4):343-51. PubMed ID: 18760890
[TBL] [Abstract][Full Text] [Related]
18. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO
Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742
[TBL] [Abstract][Full Text] [Related]
19. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
[TBL] [Abstract][Full Text] [Related]
20. Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.
Domené HM; Hwa V; Argente J; Wit JM; Camacho-Hübner C; Jasper HG; Pozo J; van Duyvenvoorde HA; Yakar S; Fofanova-Gambetti OV; Rosenfeld RG;
Horm Res; 2009; 72(3):129-41. PubMed ID: 19729943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
